Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Adempas (Riociguat, BAY63-2521)1件: Riociguat1件: Riociguat 💬 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 88 💬
2BAY63-2521----3件: 51, 86, 299 💬
3Riociguat (Adempas, BAY63-2521)1件: Riociguat1件: Riociguat 💬 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬4件: 51, 86, 88, 299 💬
4Riociguat (BAY63-2521)1件: Riociguat1件: Riociguat 💬 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬